Log in

Compare Stocks

Enter up to five stock symbols separated by a comma or space (ex. BAC,WFC,JPM,LON:BARC).
Date Range: 

 Axovant Gene TherapiesCheckpoint TherapeuticsTapImmuneAraviveMillendo Therapeutics
SymbolNASDAQ:AXGTNASDAQ:CKPTNASDAQ:MRKRNASDAQ:ARAVNASDAQ:MLND
Price Information
Current Price$3.21$2.10$2.19$12.62$2.18
52 Week RangeBuyBuyBuyBuyBuy
Beat the Market™ Rank
Overall Score1.91.21.21.61.6
Analysis Score3.43.53.43.53.4
Community Score2.62.62.42.52.4
Dividend Score0.00.00.00.00.0
Ownership Score3.00.00.02.01.0
Earnings & Valuation Score0.60.00.00.01.3
Analyst Ratings
Consensus RecommendationBuyBuyBuyBuyBuy
Consensus Price Target$16.70$11.50$8.90$26.00$11.00
% Upside from Price Target420.25% upside447.62% upside306.39% upside106.02% upside404.59% upside
Trade Information
Market Cap$116.36 million$115.62 million$105.16 million$201.27 million$41.42 million
Beta1.551.910.533.511.53
Average Volume156,463253,651622,991118,7231,159,675
Sales & Book Value
Annual RevenueN/A$1.71 million$210,000.00$4.75 million$290,000.00
Price / SalesN/A67.62485.2442.38142.83
CashflowN/AN/AN/AN/AN/A
Price / CashN/AN/AN/AN/AN/A
Book Value$2.47 per share$0.34 per share$0.96 per share$4.71 per share$3.28 per share
Price / BookN/A6.182.282.680.66
Profitability
Net Income$-129,070,000.00$-24,710,000.00$-21,430,000.00$-18,220,000.00$-44,570,000.00
EPS($8.02)($0.70)($0.47)($1.57)($3.25)
Trailing P/E RatioN/AN/AN/AN/AN/A
Forward P/E RatioN/AN/AN/AN/AN/A
P/E GrowthN/AN/AN/AN/AN/A
Net MarginsN/A-949.53%N/AN/AN/A
Return on Equity (ROE)-241.62%-182.15%-49.42%-37.54%-86.21%
Return on Assets (ROA)-75.95%-111.25%-46.19%-30.30%-68.49%
Dividend
Annual PayoutN/AN/AN/AN/AN/A
Dividend YieldN/AN/AN/AN/AN/A
Three-Year Dividend GrowthN/AN/AN/AN/AN/A
Payout RatioN/AN/AN/AN/AN/A
Years of Consecutive Dividend GrowthN/AN/AN/AN/AN/A
Debt
Debt-to-Equity Ratio1.28%N/A0.01%0.12%0.04%
Current Ratio1.09%3.32%13.27%12.36%5.76%
Quick Ratio1.09%3.32%13.27%12.36%5.76%
Ownership Information
Institutional Ownership Percentage31.58%10.27%32.07%41.74%66.40%
Insider Ownership Percentage5.50%9.80%30.90%39.80%3.70%
Miscellaneous
Employees457111437
Shares Outstanding36.82 million55.06 million46.53 million15.95 million19.00 million
Next Earnings Date6/9/2020 (Estimated)8/13/2020 (Estimated)8/13/2020 (Estimated)8/5/2020 (Estimated)8/10/2020 (Estimated)
OptionableOptionableNot OptionableOptionableOptionableNot Optionable

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.